3SBIO 2025 ESG Report: A-Level Rating, 48.49% Cut in Carbon Intensity and Full Anti-Corruption Coverage

Bulletin Express04-29

3SBIO released its 2025 Environmental, Social and Governance (ESG) Report, receiving an “A” rating from SynTao Green Finance and maintaining a “B” score from CDP’s Climate Change questionnaire for the sixth consecutive year.

Environmental Highlights • Greenhouse-gas emissions intensity dropped 48.49% year-on-year to 0.0380 tCO₂e per RMB10,000 of revenue. • Hazardous-waste intensity fell 56.77% to 0.3881 kg/RMB10,000, while non-hazardous-waste intensity declined 40.44% to 0.2700 kg/RMB10,000. • All operating manufacturing bases hold ISO 14001 certification, and Sunshine Guojian has been named a national-level Green Factory.

Social Indicators • Average training hours reached 21.28 per employee. • Employee turnover rate improved to 20.39%, a 9.83% year-on-year reduction. • Company-wide health and safety efforts resulted in zero work-related fatalities and a decrease in lost-work days to 70.

Governance Metrics • Anti-corruption training coverage hit 100% for both Board members and employees; the Board links remuneration to key ESG indicators. • An ESG Committee, led by directors, oversees strategy while an ESG Working Group executes daily tasks across functions including R&D, manufacturing and marketing.

Climate Strategy • Scenario analysis under NGFS “Net Zero 2050” and IPCC SSP pathways identified typhoons and water scarcity as principal physical risks and projected manageable transition costs. • The firm met its 2025 target of reducing carbon intensity 20% from a 2017 baseline, achieving a 41.54% cut.

Product & Supply Chain • No product recalls were recorded, and complaint handling rate remained at 100%. • 89.51% of suppliers underwent environmental, labor and ethics assessments; 3SBIO advanced localisation and second-source development to strengthen supply resilience.

Stakeholder Engagement • More than 15,100 grassroots medical personnel were trained through the Ankylosing Spondylitis-Based Healthy Village programme, which screened 10,582 patients and provided RMB8.13 million in treatment grants.

The Board of Directors reviews ESG performance at least twice a year and has pledged further emissions, resource-efficiency and waste-reduction targets beyond 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment